See All Slides - tctmd.com

Slides

Presentation TCT 2012

TCT-101. 12-month Results of a 2nd Generation Transapical Aortic Bioprosthesis for the Treatment of Patients with Severe Aortic Stenosis

Presenter: Joerg Kempfert

October 23, 2012

Presentation TCT 2012

Atrial Fibrillation:
1. CHADS2 vs. CHA2DS2-VASc Risk Assessment.
2. AHA/ACC vs. ACCP/ESC Approach to Stroke Prevention.

Presenter: Peter Brady

October 23, 2012

Presentation TCT 2012

Case 3: During an Iliofemoral Intervention

Presenter: D. Christopher Metzger

October 23, 2012

Presentation TCT 2012

TCT-76. Predictive Value of the J-CTO Score in Percutaneous Coronary Interventions for Chronic Total Occlusions

Presenter: Yves Louvard

October 23, 2012

Presentation TCT 2012

Overview: Addressing Structure in Structural Heart Disease

Presenter: Robert Michler

October 23, 2012

Presentation TCT 2012

CorAssist

Presenter: Mitchell Krucoff

October 23, 2012

Presentation TCT 2012

Late Breaking Clinical Trials: BRIDGE-ACS (Multimodality Approach to Adherence), INFUSE-AMI (STEMI), and IMMEDIATE (GIK)

Presenter: Ajay Kirtane

October 23, 2012

Presentation TCT 2012

TCT-67. Impact of Hemodynamic Support with Impella vs. Intraaortic Balloon Counterpulsation on Prognostically Important Ischemic Endpoints: Results from the PROTECT-II Trial

Presenter: George Dangas

October 23, 2012

Presentation TCT 2012

MitraClip in Patients with CHF

Presenter: Stephan Baldus

October 23, 2012

Presentation TCT 2012

Subcutaneous Defibrillators

Presenter: Gust Bardy

October 23, 2012

Advertisement

Slides

TCT-101. 12-month Results of a 2nd Generation Transapical Aortic Bioprosthesis for the Treatment of Patients with Severe Aortic Stenosis

Atrial Fibrillation:
1. CHADS2 vs. CHA2DS2-VASc Risk Assessment.
2. AHA/ACC vs. ACCP/ESC Approach to Stroke Prevention.

Case 3: During an Iliofemoral Intervention

TCT-76. Predictive Value of the J-CTO Score in Percutaneous Coronary Interventions for Chronic Total Occlusions

Overview: Addressing Structure in Structural Heart Disease

CorAssist

Late Breaking Clinical Trials: BRIDGE-ACS (Multimodality Approach to Adherence), INFUSE-AMI (STEMI), and IMMEDIATE (GIK)

TCT-67. Impact of Hemodynamic Support with Impella vs. Intraaortic Balloon Counterpulsation on Prognostically Important Ischemic Endpoints: Results from the PROTECT-II Trial

MitraClip in Patients with CHF

Subcutaneous Defibrillators

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content